Drug record
What four public record sets show for atorvastatin. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.023 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $784.2 million | Details |
| FDA recall records | 68 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Atorvastatin 10 Mg Tablet: pharmacies pay about $0.023 each, or $0.690 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| ATORVASTATIN 10 MG TABLET | Generic | $0.023 per each | $0.690 | Oct 21, 2026 |
| ATORVASTATIN 20 MG TABLET | Generic | $0.029 per each | $0.857 | Oct 21, 2026 |
| ATORVASTATIN 40 MG TABLET | Generic | $0.037 per each | $1.11 | Oct 21, 2026 |
| ATORVASTATIN 80 MG TABLET | Generic | $0.068 per each | $2.04 | Oct 21, 2026 |
| ATORVALIQ 20 MG/5 ML SUSP | Brand | $1.23 per mL | — | Oct 1, 2026 |
| LIPITOR 10 MG TABLET | Brand | $13.42 per each | $402.55 | Oct 21, 2026 |
| LIPITOR 20 MG TABLET | Brand | $19.06 per each | $571.75 | Oct 21, 2026 |
| LIPITOR 40 MG TABLET | Brand | $19.12 per each | $573.68 | Oct 21, 2026 |
| LIPITOR 80 MG TABLET | Brand | $19.04 per each | $571.34 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $784.2 million for the 3 products below. That is down 10% from $872.9 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Atorvastatin Calcium Atorvastatin Calcium | $756.5 million | 17,830,813 | $10.31 | $42.43 | $799.7 million |
| Lipitor Atorvastatin Calcium | $26.8 million | 6,920 | $1,151.67 | $3,872.57 | $73.1 million |
| Atorvaliq Atorvastatin Calcium | $932,042 | 783 | $355.74 | $1,190.35 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Amlodipine-Atorvastatin, Caduet.
Recalls reported to the FDA that name this drug.
The FDA has 68 recall records that name atorvastatin in the product description (42 Class II · 26 Class III). 9 are still marked ongoing.
Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
Reason: Presence of Foreign Tablets/Capsules
Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054
Reason: Failed Dissolution Specifications
Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDC 67877-512-05), c). 1000-count(NDC 67877-512-10),Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
Reason: Failed Dissolution Specifications
Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05), c). 1000-count bottle (NDC 67877-511-10) Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
Reason: Failed Dissolution Specifications
Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c). 1000-count (NDC 67877-513-10), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
Reason: Failed Dissolution Specifications
Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13
Reason: Failed dissolution specifications: lower than specifications
Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.
Reason: Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-946-52
Reason: CGMP Deviations
Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Reason: cGMP Deviations
Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Reason: cGMP Deviations
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for atorvastatin. This page is public-record information, not medical advice.